TRPM3 (Transient Receptor Potential Cation Channel Subfamily M Member 3) is a calcium-permeable nonselective cation channel belonging to the TRPM (Melastatin) subfamily of the Transient Receptor Potential channel family. First characterized in 2002, TRPM3 has emerged as an important channel in sensory physiology, endocrine function, and more recently, in neurodegeneration. Located on chromosome 9q21.11 in humans, the TRPM3 gene encodes a protein of approximately 168 kDa that forms hexameric channels in the plasma membrane. TRPM3 is activated by multiple stimuli including heat, endogenous ligands such as sphingosine and its derivatives, and synthetic chemical agonists. Its expression in sensory neurons, pancreatic beta cells, and various brain regions makes it a versatile channel with diverse physiological roles. Recent research has highlighted TRPM3's involvement in neurodegenerative diseases, making it a protein of significant interest for understanding disease mechanisms and developing therapeutic interventions.
[^2]
[^3]
[^4]
[^5]
[^6]
[^7]
[^8]
[^9]
[^10]
| TRPM3 Protein |
|---|
| Protein Name | Transient Receptor Potential Cation Channel Subfamily M Member 3 |
| Gene | [TRPM3](/genes/trpm3) |
| UniProt ID | [Q9QYZ4](https://www.uniprot.org/uniprot/Q9QYZ4) |
| Molecular Weight | ~168 kDa (1528 aa) |
| Subcellular Localization | Cell membrane, intracellular vesicles |
| Protein Family | TRP channel family, TRPM subfamily |
| Expression | Brain, sensory neurons, pancreas, kidney |
TRPM3 shares the canonical architecture of TRP channel proteins:
- N-terminal region: Contains six conserved MHR (MELASTATIN Homology Regions) domains involved in tetramerization and regulation
- Transmembrane domain: Six transmembrane helices (S1-S6) with a pore loop between S5 and S6
- C-terminal region: Contains a TRP domain (characteristic of TRP channels) and calmodulin-binding sites
- Channel assembly: Forms functional channels as homomers or heteromers with other TRP channels (particularly TRPM1 and TRPM6)
The channel pore has a relatively low selectivity for calcium over sodium (PCa/PNa ≈ 3-5), making it a significant route for calcium entry into cells. Multiple splice variants of TRPM3 have been identified, with some showing distinct pharmacological profiles and subcellular localization.
TRPM3 is expressed in sensory neurons of the dorsal root ganglia (DRG) and trigeminal ganglia:
- Thermoreception: Activated by noxious heat (>35°C), contributing to heat pain detection
- Nociception: Mediates pain signaling in response to various noxious stimuli
- Chemesthesis: Responds to chemical irritants including capsaicin analogs
In various cell types, TRPM3-mediated calcium entry regulates:
- Hormone secretion: In pancreatic beta cells, TRPM3 contributes to insulin secretion
- Cell proliferation: Calcium entry regulates cell cycle progression
- Gene expression: Calcium-dependent transcription factor activation
In the central nervous system, TRPM3 is expressed in:
- Hippocampus: Pyramidal neurons and interneurons
- Cerebral cortex: Layer-specific expression in cortical neurons
- Cerebellum: Purkinje cells and granule cells
- Hypothalamus: Neuroendocrine neurons
TRPM3 dysregulation has been implicated in Alzheimer's disease pathogenesis:
- Calcium homeostasis disruption: Altered TRPM3 function may contribute to abnormal calcium signaling in neurons
- Amyloid-beta interaction: Aβ oligomers can modulate TRPM3 activity, potentially leading to toxic calcium influx
- Synaptic dysfunction: TRPM3-mediated calcium dysregulation may contribute to synaptic loss
- Neuronal vulnerability: Altered channel expression in AD brains may increase neuronal susceptibility to damage
In dopaminergic neurons, TRPM3 may play protective or pathological roles:
- Oxidative stress response: TRPM3 activation can induce oxidative stress in dopaminergic cells
- Mitochondrial dysfunction: Calcium dysregulation through TRPM3 may exacerbate mitochondrial impairment
- Neuroinflammation: Channel activation on glial cells may modulate inflammatory responses
¶ Epilepsy and Developmental Disorders
TRPM3 mutations cause inherited epilepsy syndromes:
- Gain-of-function mutations: Lead to hyperexcitability and seizure disorders
- Developmental delay: Associated with intellectual disability and autism spectrum disorders
- Therapeutic targeting: TRPM3 antagonists show anti-seizure potential
Emerging evidence suggests TRPM3 involvement in motor neuron disease:
- Motor neuron excitability: Altered calcium handling through TRPM3 may contribute to excitotoxicity
- Glial dysfunction: Astrocyte and microglia TRPM3 may modulate neuroinflammation
TRPM3 may play roles in demyelination and neuroinflammation:
- Oligodendrocyte biology: TRPM3 expression in oligodendrocytes suggests roles in myelin maintenance
- Immune modulation: Channel activity on immune cells may regulate inflammatory responses
TRPM3 can be activated by multiple compounds:
- Heat: Physiological activation above 35°C
- Sphingosine: Endogenous lipid activator
- Pregnenolone sulfate: Neurosteroid activator
- CIM0216: Synthetic TRPM3 agonist
- Cucurbitacin E: Plant-derived activator
Multiple TRPM3 antagonists have been developed:
- Miconazole: Antifungal with TRPM3-blocking activity
- Ruthenium red: Nonspecific TRPM blocker
- Compound 31: Selective TRPM3 antagonist
- DA-9801: Natural product-derived antagonist
TRPM3 represents a promising drug target:
- Pain therapeutics: TRPM3 antagonists may treat chronic pain
- Epilepsy: Modulating TRPM3 may reduce seizure frequency
- Neuroprotection: TRPM3 modulators may protect against neurodegeneration
TRPM3 expression and activity may serve as:
- Disease progression markers
- Therapeutic response indicators
- Patient stratification markers
TRPM3 interacts with various proteins:
| Partner |
Interaction Type |
| TRPM1 |
Heteromer formation |
| TRPM6 |
Heteromer formation |
| Calmodulin |
Calcium-dependent regulation |
| PI3K |
Downstream signaling |
| PKC |
Phosphorylation regulation |
Studying TRPM3 in neurodegeneration involves multiple approaches:
- Electrophysiology: Patch-clamp recordings to measure channel activity
- Calcium imaging: Fluorescent calcium indicators to track calcium entry
- Molecular biology: siRNA knockdown, CRISPR editing
- Animal models: Transgenic mice with altered TRPM3 expression
- Histology: Immunohistochemistry in brain tissue
TRPM3 is a versatile calcium-permeable cation channel with important roles in sensory physiology, endocrine function, and increasingly recognized functions in neurodegeneration. Its dysregulation in Alzheimer's disease, Parkinson's disease, epilepsy, and other neurological conditions makes it a protein of significant therapeutic interest. Further research into TRPM3 function and modulation may reveal new approaches for treating neurodegenerative diseases.